PJ

Phil Jones

North America, Oklahoma, United States, Norman

Description

Phil Jones

Investor Profile

Phil Jones has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Sports
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Phil Jones frequently co-invest with?

MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
PLG Ventures
North America, California, United States, Santa Monica
Co-Investments: 1
ValueStream Ventures
North America, New York, United States, New York
Co-Investments: 1
UpWest
North America, California, United States, Palo Alto
Co-Investments: 1
J Ventures
North America, New York, United States, New York
Co-Investments: 1
Blumberg Capital
North America, California, United States, San Francisco
Co-Investments: 1
Joyance Partners
North America, California, United States, San Francisco
Co-Investments: 1
Resolute Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does Phil Jones often collaborate with?

KP
North America, Massachusetts, United States, Boston
Shared Deals: 1
JC
Europe, Catalonia, Spain, Barcelona
Shared Deals: 1
JC
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Shared Deals: 1

What are some of recent deals done by Phil Jones?

Zone7

Palo Alto, California, United States

Zone7 is an AI platform to optimize human performance by protecting health, potential, and durability of athletes & elite workforce.

Artificial Intelligence (AI)Health CareMachine LearningSports
Series AJul 22, 2021
Amount Raised: $8,000,000
Tetherex Pharmaceuticals

Oklahoma City, Oklahoma, United States

Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business.

BiotechnologyHealth CarePharmaceutical
Series BApr 18, 2018
Amount Raised: $50,000,000